Age-Related Macular Degeneration: A Disease of Systemic or Local Complement Dysregulation?

Abstract

Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in developed countries. The role of complement in the development of AMD is now well-established. While some studies show evidence of complement dysregulation within the eye, others have demonstrated elevated systemic complement activation in association with AMD. It is unclear which one is the primary driver of disease. This has important implications for designing novel complement-based AMD therapies. We present a summary of the current literature and suggest that intraocular rather than systemic modulation of complement may prove more effective.

Keywords

• age-related macular degeneration
• complement pathway
• complement system proteins/genetics
• pathway analysis
• proteomics